APNHY
Price
$5.92
Change
+$0.01 (+0.17%)
Updated
Sep 5 closing price
Capitalization
2.6B
QNTM
Price
$12.98
Change
-$1.08 (-7.68%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
54.15M
Interact to see
Advertisement

APNHY vs QNTM

Header iconAPNHY vs QNTM Comparison
Open Charts APNHY vs QNTMBanner chart's image
Aspen Pharmacare Holdings
Price$5.92
Change+$0.01 (+0.17%)
Volume$4.29K
Capitalization2.6B
Quantum Biopharma
Price$12.98
Change-$1.08 (-7.68%)
Volume$3.06K
Capitalization54.15M
APNHY vs QNTM Comparison Chart in %
Loading...
APNHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APNHY vs. QNTM commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APNHY is a Hold and QNTM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (APNHY: $5.93 vs. QNTM: $14.06)
Brand notoriety: APNHY and QNTM are both not notable
APNHY represents the Pharmaceuticals: Generic, while QNTM is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: APNHY: 96% vs. QNTM: 74%
Market capitalization -- APNHY: $2.6B vs. QNTM: $54.15M
APNHY [@Pharmaceuticals: Generic] is valued at $2.6B. QNTM’s [@Biotechnology] market capitalization is $54.15M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APNHY’s FA Score shows that 1 FA rating(s) are green whileQNTM’s FA Score has 0 green FA rating(s).

  • APNHY’s FA Score: 1 green, 4 red.
  • QNTM’s FA Score: 0 green, 5 red.
According to our system of comparison, both APNHY and QNTM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APNHY’s TA Score shows that 4 TA indicator(s) are bullish while QNTM’s TA Score has 5 bullish TA indicator(s).

  • APNHY’s TA Score: 4 bullish, 6 bearish.
  • QNTM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, QNTM is a better buy in the short-term than APNHY.

Price Growth

APNHY (@Pharmaceuticals: Generic) experienced а -1.41% price change this week, while QNTM (@Biotechnology) price change was -16.59% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.30%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +86.94%.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.13%. For the same industry, the average monthly price growth was +10.99%, and the average quarterly price growth was +33.00%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.30% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

@Biotechnology (+2.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APNHY($2.6B) has a higher market cap than QNTM($54.1M). QNTM YTD gains are higher at: 281.929 vs. APNHY (-28.269). APNHY has higher annual earnings (EBITDA): 8.02B vs. QNTM (-26.86M). APNHY has more cash in the bank: 6.8B vs. QNTM (1.53M). QNTM has less debt than APNHY: QNTM (2.27M) vs APNHY (35.5B). APNHY has higher revenues than QNTM: APNHY (45.5B) vs QNTM (0).
APNHYQNTMAPNHY / QNTM
Capitalization2.6B54.1M4,802%
EBITDA8.02B-26.86M-29,866%
Gain YTD-28.269281.929-10%
P/E Ratio10.28N/A-
Revenue45.5B0-
Total Cash6.8B1.53M445,288%
Total Debt35.5B2.27M1,567,329%
FUNDAMENTALS RATINGS
APNHY vs QNTM: Fundamental Ratings
APNHY
QNTM
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
8637
P/E GROWTH RATING
1..100
93100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APNHY's Valuation (9) in the null industry is somewhat better than the same rating for QNTM (72). This means that APNHY’s stock grew somewhat faster than QNTM’s over the last 12 months.

APNHY's Profit vs Risk Rating (100) in the null industry is in the same range as QNTM (100). This means that APNHY’s stock grew similarly to QNTM’s over the last 12 months.

APNHY's SMR Rating (99) in the null industry is in the same range as QNTM (100). This means that APNHY’s stock grew similarly to QNTM’s over the last 12 months.

QNTM's Price Growth Rating (37) in the null industry is somewhat better than the same rating for APNHY (86). This means that QNTM’s stock grew somewhat faster than APNHY’s over the last 12 months.

APNHY's P/E Growth Rating (93) in the null industry is in the same range as QNTM (100). This means that APNHY’s stock grew similarly to QNTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APNHYQNTM
RSI
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
55%
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 5 days ago
60%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 4 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
69%
Bullish Trend 12 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
58%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
78%
Aroon
ODDS (%)
Bearish Trend 4 days ago
59%
Bullish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
APNHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESALF32.320.02
+0.06%
Eisai Co., Ltd.
LOGN31.00N/A
N/A
Logansport Financial Corp.
ASUUF11.59N/A
N/A
A SPAC II Acquisition Corp.
LHYFF4.72N/A
N/A
LHYFE S A
VTKLY7.79-0.35
-4.32%
VTech Holdings, Ltd.

APNHY and

Correlation & Price change

A.I.dvisor tells us that APNHY and TEVA have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APNHY and TEVA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHY
1D Price
Change %
APNHY100%
+0.08%
TEVA - APNHY
23%
Poorly correlated
+2.54%
PRFX - APNHY
18%
Poorly correlated
-12.62%
QNTM - APNHY
17%
Poorly correlated
-1.64%
YCBD - APNHY
0%
Poorly correlated
+1.44%
ABSCF - APNHY
0%
Poorly correlated
N/A
More

QNTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNTM has been loosely correlated with HYPD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if QNTM jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
-1.64%
HYPD - QNTM
34%
Loosely correlated
N/A
ATHE - QNTM
27%
Poorly correlated
N/A
ATAI - QNTM
26%
Poorly correlated
+0.22%
CPIX - QNTM
26%
Poorly correlated
-9.56%
DYN - QNTM
26%
Poorly correlated
+7.40%
More